The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Oxford, United Kingdom
1-10 Employees
2022
We deliver a service starting from hybridoma creation from your selected antigen, through screening and culture, to purification of the chosen clones. Each part of our service can be utilised independently, such as growth and/or purification of your own hybridoma, or conjugation of your own antibody or one chosen from our own range. Our goal is to be recognised for the science we do and to have a track record of success for our clients. We provide complete cost-effective services for the development and production of antibodies. Fagus Antibody Services is made up of a team of experienced scientists to provide a complete package in antibody development.
-
- Employees
-
We are happy to announce that we are an official supplier for the Canadian Government. We are passionate about providing customers with outstanding value for money. With upto 75% OFF on products, we want to help you save big this year! GeneBio Systems is a team of specialists dedicated to providing high-performance, and cost-effective products. We strive to serve the scientific community by offering laboratory products for both clinical and academic research. Supporting some of the most research-intensive institutions in Canada, we are committed to fufilling laboratory needs in all aspects of Molecular and Cellular Biology. Established in 2011 in Toronto Ontario, GeneBio Systems is a small yet rapidly growing company in the biotechnology industry. GeneBio Systems prides itself on the value, quality, and customer service it provides through its products and services.
Novi, United States
11-50 Employees
1998
We are happy to help you find exactly what you need to keep your research going. Innovative Research was established more than 20 years ago after the realization that dependable, high-quality, and affordable research materials were hard to come by. Innovative Research has been an industry-leading, privately-owned supplier of biological research reagents for over two decades. Since those humble beginnings the company has greatly expanded its product offerings and along the way has experienced tremendous growth. Innovative Research currently manufactures and supplies researchers with over 25,000 high-quality human and animal biologics including blood products, tissues, proteins, polyclonal and monoclonal antibodies, ELISA kits, viral transport media and more. For over twenty years, Innovative Research has placed customer service as our highest priority. Through this acquisition, Innovative Research is able to leverage Molecular Innovation's decades of experience and cutting edge technology in manufacturing research biologicals to further improve the quality and production processes of their products. Read the Press Release to find out more details regarding the acquisition and Innovative Research's vision moving forward.
Huron Charter Township, United States
101-250 Employees
2007
Learn about the processes and extra steps we take to deliver the highest performing antibodies straight to your bench. Alternatively use it as a simple call to action with a link to a product or a page.
Troisdorf, Germany
11-50 Employees
1992
That is why we are always at your side with competent advice. Good accessibility We are there for you on weekdays from 9.00 to 17.00. CellSystems` product portfolio comprises a range of products for cell biology research and in vitro toxicology studies. Founded in 1992 as a sales and marketing organization for primary cells and selective media (cell-systems), CellSystems is today your European partner for life science research products. Looking back at nearly 30 years of experience with highly sophisticated research products in this challenging market, we know from our own experience the importance of reproducibility, batch to batch consistency, and reliability, but also the significance to comply with cold chain requirements, import and export regulations, veterinarian approval, ISO certified processes and further important standards. Knowing that every experimental setup and protocol varies to a certain grade, our experts are here to support your science with our comprehensive experience with each single product. To ensure that you get the right product for your application, we will be happy to assist you in detail regarding various possible applications. You have product related questions or like to start an inquiry?
Fremont, United States
11-50 Employees
2001
Biotium is a leading life science reagent manufacturer and supplier devoted to providing high-quality and innovative fluorescent tools that fuel scientific discovery. Biotium is uniquely poised to invent cutting-edge products through the synergy of chemistry and biology. Biotium is based in the San Francisco Bay Area, with distribution channels across the globe. Biotium has licensed many of its patented technologies to a number of major international biotech companies including Agilent, BD Biosciences, Biolegend, BioRad, EMD Millipore, Illumina, PerkinElmer, Qiagen, Roche, Sartorius AG, Sigma-Aldrich, Thermo Fisher Scientific, and several others. These partnerships extend Biotium’s reach to more customers and expand applications of Biotium’s cutting-edge technologies in life science research, medical diagnostics, and pharmaceutical science. Biotium is certified under an ISO 9001:2015 quality management system. Biotium's new BactoSpore™ Bacterial Stains were developed to tackle the challenge of endospore detection by offering bright staining of endospores as well as live and dead bacteria for microscopy or flow cytometry. A leading provider of innovative fluorescent solutions for scientists.
Malmo, Sweden
11-50 Employees
1992
We provide immunoassays and Mechanism of Action (MoA) cellular assays catering to all phases of drug development, serving commercial labs, research facilities, and clinical diagnostics. We are committed to advancing scientific discovery through our expertise and cutting-edge technologies. We are committed to revolutionizing IBD patient care with E-Health, an emerging technology that allows patients to stay in remission for extended periods. We provide cutting-edge products, versatile assay solutions, and services that help our clients get the answers they need for their drug development or basic research projects. As Life Science moves forward, more and more innovative tools and techniques emerge that will change the field of life science and healthcare. Someone has to provide stable and reliable solutions for identifying the right techniques and generating solid data from them. We aim to deliver tailored solutions, create practical platforms for routine clinical testing, and share knowledge to enhance competencies through partnerships. We work to deliver the right answers at the right time to improve patient care and accelerate drug development.
Singapore, Singapore
11-50 Employees
2021
Antrim, United Kingdom
51-100 Employees
-
Our products are created using accurate and reliable technology made in our high tech laboratories. We are dedicated to developing market leading products and are committed to investing in the research and development of new products and collaborating with external research facilities and universities globally. We specialise in the development, manufacturing and distribution of a range of Medical Diagnostic and Point of Care Tests for a global market. Biorex Diagnostics is a rapidly expanding, innovative primary diagnostics manufacturer based in the United Kingdom. We offer detailed technical support and training to our distributors on our product range and new developments. We continually invest in R&D to ensure we deliver products that meet market needs. A key element in Biorex’s strategy is to provide its customers and distributors with high quality products which will continue to meet the market needs and performance expectations. If you have any questions or queries on any item in our product lines, wish to contact your local distributor or to discuss distribution in areas where the company is not represented, please contact Biorex and one of their marketing teams will be delighted to help you.
San Diego, United States
1-10 Employees
2012
Xcess Biosciences Inc (XcessBio or Xbio) was founded in 2008 by scientists from academia and BioPharma industry with strong expertise in chemistry and biology. We are dedicated to develop high-quality products and deliver the best services for our customers. We diligently develop high quality products and strive to earn your satisfaction. If you know of any technology, product, or service development opportunities in the fields related, we would be very interested in hearing from you. SD70 is a potent, selective and cell-permeable inhibitor of histone demethylase JMJD2 (KDM4C), identified by phenotypic screening for inhibitors of ligand and genotoxic stress-induced translocations in prostate cancer cells.
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Carbonic Anhydrase
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 18 |
| Amount of suitable service providers | 14 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1992 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
Carbonic anhydrase is an enzyme that catalyzes the rapid conversion of carbon dioxide and water into bicarbonate and protons (hydrogen ions), a reversible reaction essential for various physiological processes in living organisms. This enzyme plays a critical role in maintaining acid-base balance in blood and other tissues, facilitating the transport of carbon dioxide out of tissues and ultimately out of the body via respiration. Carbonic anhydrase is abundant in red blood cells but is also found in other tissues, including the kidneys, where it aids in the reabsorption of bicarbonate, and the eye, contributing to the secretion of aqueous humor. Its activity is of paramount importance in the regulation of pH in blood and other bodily fluids, which is crucial for the normal functioning of cells and organs. Moreover, carbonic anhydrase has significant implications in medical and industrial fields; it is a target for diuretic drugs treating conditions like glaucoma, epilepsy, and altitude sickness. Additionally, its efficiency in catalyzing CO2 conversion is being explored in carbon capture technologies, which aim to reduce carbon dioxide emissions and mitigate climate change. The enzyme's versatility and essential role in biochemical processes highlight its importance across various disciplines, from physiology and medicine to environmental science.
1. Improved Efficiency
Carbonic Anhydrase significantly enhances the speed of carbon dioxide (CO2) conversion to bicarbonate and protons, outperforming many alternative chemical methods. This rapid reaction time is crucial in physiological processes, such as respiration and acid-base balance, making it indispensable in medical and industrial applications.
2. Environmental Impact
This enzyme plays a pivotal role in carbon sequestration processes, offering a green solution to reducing atmospheric CO2 levels. Its ability to facilitate the capture and conversion of CO2 into harmless by-products is a sustainable alternative to traditional carbon capture technologies, which are often energy-intensive and costly.
3. Versatility
Carbonic Anhydrase is highly adaptable, functioning effectively across a wide range of conditions. This versatility makes it suitable for various applications, from enhancing photosynthesis in agriculture to improving the efficiency of carbon capture systems in industrial settings. Its broad utility is a significant advantage over more specialized or condition-sensitive alternatives.
While evaluating the different suppliers make sure to check the following criteria:
1. Quality Assurance
Verify if the supplier provides detailed product specifications and quality certifications. High purity and activity levels are crucial for Carbonic Anhydrase's effectiveness in applications.
2. Regulatory Compliance
Ensure the supplier adheres to global regulatory standards, including environmental, health, and safety regulations. Compliance certificates are a must-have.
3. Supply Chain Stability
Assess the supplier's ability to provide consistent and reliable delivery schedules. A robust supply chain minimizes the risk of disruptions.
4. Technical Support
Check the availability of technical support and consultation services. Knowledgeable support can be invaluable for application-specific inquiries.
5. Customization Capability
Determine if the supplier offers customization options, such as formulation adjustments, to meet specific application needs.
6. Cost-effectiveness
Consider the overall value offered by the supplier, balancing cost with quality, reliability, and support services.
7. Sustainability Practices
Evaluate the supplier's commitment to sustainable and eco-friendly practices, which is increasingly important in today's market.
Carbonic Anhydrase plays a pivotal role in the medical industry, particularly in the development and enhancement of diuretics. These enzymes are crucial in managing conditions such as glaucoma, epilepsy, and altitude sickness by regulating the acid-base balance in the body. Their ability to facilitate the rapid conversion of carbon dioxide and water into bicarbonate and protons makes them invaluable in creating effective treatments. In the industrial sector, carbonic anhydrase accelerates carbon capture processes. This application is particularly beneficial in mitigating environmental impacts, as it aids in reducing carbon dioxide emissions from industrial activities. Companies engaged in sustainability and environmental conservation efforts find this enzyme essential for incorporating green technology solutions into their operations. The enzyme also finds significant applications in the beverage industry, where it is used to speed up the clarification process of alcoholic drinks. By catalyzing the conversion of carbon dioxide, carbonic anhydrase helps in maintaining the desired acidity and flavor profile of beverages, ensuring product consistency and quality. Furthermore, carbonic anhydrase contributes to enhanced biomass productivity in the biofuel industry. It optimizes CO2 uptake in bio-reactors, thereby increasing the growth rate of microalgae used in biofuel production. This application underscores the enzyme’s versatility in promoting sustainability and efficiency across various sectors.
Carbonic anhydrase, an enzyme pivotal in accelerating the conversion of carbon dioxide to bicarbonate and protons, currently finds itself at various Technology Readiness Levels (TRLs) depending on its application scope. In biomedical applications, such as drug development for glaucoma treatment or genetic disorders, it is at a higher TRL, approximately TRL 6-7, demonstrating proof of concept in relevant environments through successful clinical trials. However, in emerging fields like carbon capture and sequestration (CCS) or biomimetic carbon sequestration, its TRL hovers around 3-4. This discrepancy arises due to the nascent stage of integrating carbonic anhydrase into industrial processes, where challenges in enzyme stability, efficiency at scale, and cost-effective production methods are yet to be fully addressed. The enzyme's susceptibility to denaturation under industrial conditions and the high costs associated with its production and purification are technical hurdles that inhibit its widespread adoption in CCS technologies. Additionally, while its potential for enhancing carbon sequestration rates is recognized, scaling up from laboratory conditions to industrial applications necessitates significant advancements in bioreactor design and enzyme immobilization techniques to maintain activity and stability. Thus, the specific TRL of carbonic anhydrase is dictated by the maturity of its application field, with technical challenges varying accordingly.
In the short-term, advancements in carbonic anhydrase technology are poised to enhance carbon capture efficiency. Researchers are focusing on genetically modifying organisms to produce carbonic anhydrase at higher rates, facilitating more effective absorption of CO2 from industrial emissions. This phase is expected to see pilot projects demonstrating the viability of these technologies in reducing carbon footprints of small to medium-sized industrial plants. Mid-term developments are anticipated to revolve around the integration of carbonic anhydrase into large-scale carbon capture and storage (CCS) systems. Breakthroughs in enzyme stability and activity under industrial conditions will allow for broader application in sectors such as power generation and manufacturing. This period will likely witness the first commercial deployments of carbonic anhydrase-enhanced CCS technologies, aiming at significant reductions in atmospheric CO2 levels. In the long-term, the focus will shift towards optimizing the use of carbonic anhydrase for direct air capture (DAC) of CO2 and its conversion into usable products. Innovations in biotechnology are expected to enable the engineering of enzymes with unprecedented efficiency, leading to the development of sustainable, closed-loop systems for carbon utilization. These advancements will contribute to a circular carbon economy, where CO2 emissions are not just reduced but repurposed into fuels, chemicals, and building materials, marking a substantial leap towards achieving global carbon neutrality.
Some interesting questions that has been asked about the results you have just received for Carbonic Anhydrase
What are related technologies to Carbonic Anhydrase?
Based on our calculations related technologies to Carbonic Anhydrase are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Who are Start-Ups in the field of Carbonic Anhydrase?
Start-Ups who are working in Carbonic Anhydrase are Fagus Antibody Services, Booksmart
Which industries are mostly working on Carbonic Anhydrase?
The most represented industries which are working in Carbonic Anhydrase are Biotechnology, Health Care, Science and Engineering, Commerce and Shopping, Manufacturing
How does ensun find these Carbonic Anhydrase Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
